The global pain management devices market was valued at $3,689.20 million in 2020, and is projected to reach $5,767.69 million by 2028, registering a CAGR of 6.3% from 2021 to 2028. Pain management is a branch of medical science, which eases the suffering of patients who suffer from chronic pain. Acute pain has sudden onset of action, whereas chronic pain persists for a longer duration, which leads to need for its management. Pain management devices are medical devices that are used in management of different types of pain such as neuropathic pain, cancer pain, nociceptive pain, musculoskeletal pain, and others.
Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are various types of pain management devices available in the market. The growth of the global pain management devices market is driven by increase in geriatric population, rise in prevalence of chronic pain, surge in geriatric population, surge in awareness among people toward pain management devices, improved R&D investment to develop innovative products, and launch of innovative products. In addition, increase in demand for pain management devices among the developing countries and rise in adoption of pain management devices for management of chronic pain are other factors that contribute toward the growth of the market. Furthermore, untapped potential offered by developing economies present lucrative opportunities for market expansion during the forecast period. However, hypersensitivity reactions and post-operative infections caused due to use of these devices limit their adoption, which hampers the growth of the market. Moreover, these devices are usually used as second line of treatment in patients with chronic pain who become resistant to drug therapy, which limits the growth of the global pain management devices market.
COVID-19 Impact
This pandemic has disrupted growth in many economies across various domains. The COVID-19 outbreak is expected to impact the growth of the pain management devices market globally. The COVID-19 pandemic has stressed healthcare systems across the globe, so that many clinics, and pain services are open for public services for only a limited period. Large number of hospitals & clinics have witnessed a drop in number of patient visits amid COVID-19 ultimately reducing client contact. Subsequently, most chronic pain facilities were deemed non-urgent, both outpatient and elective interventional procedures were limited or stopped during the COVID-19 pandemic to minimize risk of the viral spread. For instance, according to the Indian Journal of Anesthesia, COVID-19 has a negative impact on the pain clinics, including interventional pain management procedures. Thus, limited availability of medical care for conditions other than COVID-19 has impacted the growth of the pain management devices market in a negative manner. At the same time, limited availability of healthcare staff across the globe is another factor, which has an undesirable effect on the pain management devices market.
Product Segment Review
On the basis of product, the pain management devices market is categorized into neuromodulation & neurostimulation devices, analgesic infusion pumps, and ablation devices. Under the neuromodulation & neurostimulation devices segment, the market is further bifurcated into spinal cord stimulators and transcutaneous electrical nerve stimulation (TENS) devices. Under the analgesic infusion pumps, the pain management devices market is further divided into external infusion pumps and intrathecal infusion pumps. Presently, the neuromodulation & neurostimulation devices dominates the global market, and is anticipated to continue this trend over the forecast period, due surge in demand for neuromodulation & neurostimulation devices, cost efficiency offered by these devices, increase in target population.
By Product
Neuromodulation and Neurostimulation Devices segment is projected as one of the most lucrative segment.
Application Segment Review
By application, the market is classified into neuropathic pain, cancer pain, facial & migraine pain, musculoskeletal pain, and others. At present, the neuropathic pain accounts for a majority of the market share, owing to surge in number of target population, technological advancements in pain management devices, and surge in demand for pain management devices for management of neuropathic pain.
By Application
Neuropathic Pain segment held a dominant position in 2020 and will continue to maintain the lead over the forecast period.
Snapshot of Asia-Pacific Pain Management Devices Market
Asia-Pacific presents lucrative opportunities for the key players operating in the pain management devices market, owing to surge in awareness about implantable pain management devices and rise in adoption of pain management devices products. Improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced medical facilities, development of the R&D sector, increase in number of target population, rise in healthcare reforms, and technological advancements in the field of healthcare further contribute toward the market growth. Some other factors such as surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high growth potential, presence of large patient base, and high disposable income are expected to drive the growth of the pain management devices market in Asia-Pacific.
By Region
Asia-Pacific would exhibit the highest CAGR of 7.9% during 2021-2028.
Key Benefits For Stakeholders
- This report provides a detailed quantitative analysis of the current pain management devices market trends and forecast estimations from 2020 to 2028, which assists to identify the prevailing market opportunities.
- An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
- A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
- The projections in this report are made by analyzing the current trends and future market potential from 2020 to 2028, in terms of value.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
- Key market players within the pain management devices market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the global pain management devices market.
Pain Management Devices Market Report Highlights
| Aspects | Details |
 By PRODUCT |
|
 By APPLICATION |
|
 By Region |
|
 Key Market Players | PFIZER INC. (HOSPIRA INC.), COLFAX CORPORATION (DJO GLOBAL LLC), KIMBERLY-CLARK CORPORATION (BAYLIS MEDICAL), B BRAUN MELSUNGEN AG, STRYKER CORPORATION, ABBOTT LABORATORIES, JOHNSON & JOHNSON (CODMAN AND SHURTLEFF, INC.), BAXTER INTERNATIONAL INC., BOSTON SCIENTIFIC CORPORATION, MEDTRONIC PLC |
Analyst Review
Neuromodulation & neurostimulation devices, analgesic infusion pumps, ablation devices, and electrostimulation devices are widely used in management of chronic pain. Rise in prevalence of chronic pain, technological advancements in pain management devices, increase in popularity of neuromodulation & neurostimulation devices, and surge in demand for pain management devices products significantly boost the growth of the pain management devices market. Moreover, rise in awareness among people toward easy availability of pain management devices, increase in healthcare expenditure, and surge in need for advanced pain management devices fuel the growth of the global pain management devices market.
North America is expected to remain dominant during the forecast period, due to higher adoption of pain management devices with large presence of key players. In addition, availability of advanced facilities and higher number of target population supplement the growth of the market. Moreover, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players during the forecast period, due to surge in target population, development in infrastructure of healthcare industry along with rise in demand for pain management devices.
The total market value of Pain Management Devices market is $3,689.2 million in 2020.
The forcast period for Pain Management Devices market is 2021 to 2028
The market value of Pain Management Devices market in 2021 is $3,771.46 million.
The base year is 2020 in Pain Management Devices market
Top companies such as Abbott Laboratories, Boston Scientific Corp, and Medtronic Plc., B Braun Melsungen AG, Baxter International Inc. , Colfax Corporation (DJO Global LLC) , and Stryker Corp. held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.
Neuromodulation & neurostimulation devices segment is the most influencing segment owing to rise in prevalence of neurological disorders such as Parkinson’s disease, migraine, and chronic pain with surge in adoption of neurostimulation & neuromodulation devices for management of pain.
Significant increase in prevalence of chronic pain, rise in geriatric population, surge in awareness among people toward pain management devices, and increase in demand for pain management devices in developing region are the key factors that fuel the growth of the market. Moreover, availability of innovative pain management devices, surge in R&D activities to develop technologically advanced pain management devices, increase in availability of lower cost portable products, and development of the medical device industry across the globe are other factors that contribute toward the growth of the market.
Asia-Pacific has the highest growth rate in the market which is growing due to the improvement in healthcare infrastructure, availability of pain management devices, surge in healthcare reforms, and technological advancements in the field of healthcare. In addition, leading manufacturers have been focusing on expanding their geographical presence in emerging Asia-Pacific countries to capture potential growth opportunities in the market.
Pain management is a branch of medical science, which eases the suffering of patients suffering from chronic pain or acute pain.
Pain management devices are medical devices, which are used in management of different types of pain such as neuropathic pain, cancer pain, nociceptive pain, and musculoskeletal pain.
Loading Table Of Content...
